137 filings
8-K
MIST
Milestone Pharmaceuticals Inc
8 Apr 24
Data from this large safety-trial also published in The Journal of the American College of Cardiology
4:38pm
8-K
MIST
Milestone Pharmaceuticals Inc
28 Mar 24
Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia
7:07am
8-K
MIST
Milestone Pharmaceuticals Inc
21 Mar 24
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Regulatory and Corporate Update
7:21am
10-K
2023 FY
MIST
Milestone Pharmaceuticals Inc
Annual report
21 Mar 24
7:01am
8-K
MIST
Milestone Pharmaceuticals Inc
4 Mar 24
Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
9:00am
424B5
hn84zakudp l2o93mre
1 Mar 24
Prospectus supplement for primary offering
4:52pm
424B5
g7c2ubt88qsm
28 Feb 24
Prospectus supplement for primary offering
5:21pm
8-K
ajx11v
26 Feb 24
Milestone Pharmaceuticals Announces Plan to Resubmit NDA for Etripamil for the Treatment of PSVT
7:06am
8-K
ezts4s1 fzr
26 Dec 23
Milestone Pharmaceuticals Receives Refusal to File Letter from U.S. FDA for New Drug Application for Etripamil in the Treatment of PSVT
7:15am
8-K
on1can1tk eq
13 Nov 23
Milestone Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Clinical and Corporate Updates
7:05am
8-K
i4yd4voabw98
13 Nov 23
Company Overview CONFIDENTIAL Atrial Fibrillation Program Update November 2023
6:37am
8-K
rwh8az8nb2mqjz
7 Nov 23
Regulation FD Disclosure
9:07am
8-K
unlw8udl
24 Oct 23
Milestone Pharmaceuticals Announces Submission of New Drug Application to the U.S. FDA for Etripamil
4:05pm
8-K
k9h7o3w
10 Aug 23
Milestone Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Corporate Update
7:40am
8-K
2xo672 uyln
9 Jun 23
Submission of Matters to a Vote of Security Holders
5:11pm
424B5
3snn1b8wb
31 May 23
Prospectus supplement for primary offering
5:19pm
EFFECT
37ru82
30 May 23
Notice of effectiveness
12:15am